tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CTMX Stock Latest News

CytomX Therapeutics announces initial data from CX-904 trial
The FlyCytomX Therapeutics announces initial data from CX-904 trial
1d ago
CTMX
CytomX Therapeutics reports Q1 EPS 17c, consensus (8c)
PremiumThe Fly
CytomX Therapeutics reports Q1 EPS 17c, consensus (8c)
2d ago
CTMX
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)
PremiumPress Releases
CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 (EGFRxCD3 PROBODY® T-Cell Engager)
2d ago
CTMX
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
2d ago
CTMX
CytomX Therapeutics options imply 56.8% move in share price post-earnings
PremiumThe Fly
CytomX Therapeutics options imply 56.8% move in share price post-earnings
2d ago
CTMX
CytomX Therapeutics, Merck enter CX-801 trial collaboration
PremiumThe FlyCytomX Therapeutics, Merck enter CX-801 trial collaboration
3d ago
MRK
CTMX
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)
PremiumPress Releases
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA® (pembrolizumab)
3d ago
CTMX
CytomX Therapeutics upgraded to Buy from Hold at Jefferies
PremiumThe Fly
CytomX Therapeutics upgraded to Buy from Hold at Jefferies
4d ago
AMGN
CTMX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7d ago
EBS
AMRN
CytomX Therapeutics extends rally, shares up 218% to $5.19
PremiumThe Fly
CytomX Therapeutics extends rally, shares up 218% to $5.19
9d ago
CTMX
BMO sees CytomX rallying after ‘surprise’ data announcement
PremiumThe Fly
BMO sees CytomX rallying after ‘surprise’ data announcement
9d ago
AMGN
CTMX
CytomX soars after saying CX-904 update coming next week
PremiumThe Fly
CytomX soars after saying CX-904 update coming next week
9d ago
CTMX
CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024
PremiumPress ReleasesCytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024
9d ago
CTMX
CytomX Therapeutics upgraded to Neutral from Underweight at JPMorgan
PremiumThe Fly
CytomX Therapeutics upgraded to Neutral from Underweight at JPMorgan
18d ago
CTMX
CytomX Therapeutics doses first patient in CX-2051 Phase 1 study
PremiumThe Fly
CytomX Therapeutics doses first patient in CX-2051 Phase 1 study
1M ago
CTMX
CytomX announces $5M milestone triggered in Astellas Pharma TCB collaboration
PremiumThe Fly
CytomX announces $5M milestone triggered in Astellas Pharma TCB collaboration
1M ago
CTMX
CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
PremiumPress Releases
CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
1M ago
CTMX
CytomX Therapeutics Welcomes New Director and Updates Bylaws
PremiumCompany Announcements
CytomX Therapeutics Welcomes New Director and Updates Bylaws
2M ago
8K
CTMX
CytomX Therapeutics appoints Zhen Su to board of directors
PremiumThe Fly
CytomX Therapeutics appoints Zhen Su to board of directors
2M ago
CTMX
CytomX Therapeutics announces milestone achievement in PROBODY TCB
PremiumThe FlyCytomX Therapeutics announces milestone achievement in PROBODY TCB
2M ago
CTMX
CytomX Therapeutics Braces for Increased Compliance Costs as it Outgrows ‘Smaller Company’ Status
PremiumCompany Announcements
CytomX Therapeutics Braces for Increased Compliance Costs as it Outgrows ‘Smaller Company’ Status
2M ago
CTMX
CytomX Therapeutics price target lowered to $3.25 from $3.30 at BMO Capital
PremiumThe Fly
CytomX Therapeutics price target lowered to $3.25 from $3.30 at BMO Capital
2M ago
CTMX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >